Why the study?
Adenosine receptor antagonism may not account for the cardiovascular action of caffeine in chronic users, so the role of a catecholamine mechanism during habitual use was examined.
Does caffeine administration alter cardiovascular parameters via the beta-1 adrenergic pathway in adult male New Zealand rabbits?
Does caffeine administration alter cardiovascular parameters via the beta-1 adrenergic pathway in adult male New Zealand rabbits?
Chronic caffeine administration in rabbits alters cardiovascular parameters through activation of the beta-1 adrenergic pathway.
Hypothesis-generating in rabbits; leaves open catecholamine role in habitual caffeine effects without clinical implications.
Background: Mechanistic studies indicate that adenosine receptor antagonism may not account for the mechanism of caffeine's cardiovascular action in chronic caffeine users. We, thus, aimed at examining the possible role of catecholamine mechanism in caffeine's cardiovascular action during habitual use. Materials and Methods: Adult male New Zealand rabbits were divided into three groups ( n = 5). Group I rabbits were untreated and served as control whereas groups II and III rabbits were administered with 2 and 6 mg/kg caffeine, respectively, for 28 days. After anesthesia arterial pressure, electrocardiogram and heart rate were recorded. Blood and cardiac tissue samples were collected for analysis. Results: After 28 days of caffeine treatment, cardiovascular parameters were significantly altered. There were increases in catecholamine level, beta-1 receptor expression, adenylate cyclase 9 immuno-reactivity, and cardiac cyclic adenosine monophosphate concentrations. Conclusion: This study demonstrates that caffeine's cardiovascular action in rabbits involves the activation of the beta-1 adrenergic pathway.
No takes yet. Share an insight, caveat, or question.
Nabofa et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: